Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
24.90
+0.30 (1.22%)
May 18, 2026, 4:00 PM EDT - Market closed
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.5 billion as of May 19, 2026. Its market cap has increased by 37,876.88% in one year.
Market Cap
1.50B
Enterprise Value
968.65M
1-Year Change
37,876.88%
Ranking
Category
Stock Price
$24.90
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.50B, an increase of 307.17%. That is a compound annual growth rate of 28.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.50B | 3,985.37% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.54B |
| Iovance Biotherapeutics | 1.54B |
| Ardelyx | 1.54B |
| Monte Rosa Therapeutics | 1.53B |
| Nuvation Bio | 1.50B |
| Novavax | 1.49B |
| Vir Biotechnology | 1.48B |
| AtaiBeckley | 1.47B |